A study to evaluate the effect of bloodletting therapy along with herbal medicine compared to herbal medicine alone in patients with fatty liver disease

A Comparative Clinical Study of Siravedhana and Sarpunkhadi Churna Versus Sarpunkhadi Churna Alone in the Management of Non-Alcoholic Fatty Liver Disease NAFLD - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/102459

Enrollment

Registered

2026-01-29

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 60 years Diagnosed case of fatty liver BMI greater than 24 Elevated lipid profile of grade 2 non-alcoholic fatty liver diesease Total Cholesterol Less than 400 mg per dL LDL Cholesterol Less than 200 mg per dL optimal HDL Cholesterol less than 40 mg per dl Triglycerides Less than 500 mg per dL. Informed and written consent for participant

Exclusion criteria

Exclusion criteria: NAFLD Grade 3 or cirrhosis Diabetes RBS greater than 200 Hb less than 10 Pregnancy or lactation Bleeding disorders Alcoholic liver disease Coagulopathies Acute abdominal pain Contraindications of raktmokshan

Design outcomes

Primary

Measure	Time frame
Reduction in fatty liver grading on USG after 45 days in the intervention groupTimepoint: baseline and 90th day	—

Secondary

Measure	Time frame
Improvement in lipid profile and BMI Relief in subjective complaints like abdominal heaviness bloating and fatigue Timepoint: baseline and 90th day	—

Countries

India

Contacts

Public ContactDr anita patel

Shree Swaminarayan Ayurvedic College kalol

dranitasudha@gmail.com9176945090

Outcome results